Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 21 years or greater~* Pt is a surgical candidate for mediastinoscopy, thoracoscopy, or lung resection~* Known or suspected non-small cell carcinoma of the lung eligible for resection~* CT scan performed within 45 days prior to evaluation for study participation~* PET scan performed within 45 days prior to evaluation for study participation~Exclusion Criteria:~* Pathologically proven metastatic disease~* History of malignancy within 5 years other than (skin) basal cell carcinoma~* Enlarged ipsilateral mediastinal lymph nodes \> 2.5 cm in diameter~* Peripheral T1 tumors with normal mediastinal lymph nodes on CT and PET

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- traditional mediastinoscopy/thoracoscopy (Type: ACTIVE_COMPARATOR): Traditional Mediastinoscopy used to detect or stage lung cancers.
- EBUS/EUS (Type: ACTIVE_COMPARATOR): Minimal invasive technique for staging/detecting lung cancer.

Based on this trial design, predict the completion outcome and termination type (if applicable).